| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.082 | 0.009 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |